Key result
Elevated hs-CRP linked to ~59% higher odds of subclinical carotid atherosclerosis, except in diabetes.
Why the study?
Does an elevated level of hs-CRP associate with increased subclinical carotid atherosclerosis in a general population stratified by glucose metabolic status?
Cross-Sectional (n=7,975)
No
Does an elevated level of hs-CRP associate with increased subclinical carotid atherosclerosis in a general population stratified by glucose metabolic status?
Systemic inflammation reflected by hs-CRP is independently associated with subclinical atherosclerosis primarily in individuals with prediabetes and normal glucose metabolism, rather than in established type 2 diabetes.
Answers are grounded in this paper and cite their sources.
hs-CRP links to carotid atherosclerosis in normoglycemia and prediabetes but not diabetes; hypothesis-generating and should not yet change practice.
BACKGROUND: Atherosclerosis is an inflammatory disease. Many studies demonstrated that hyperglycemia is not only increased inflammatory response, but also is a cause of atherosclerosis, implying that glucose metabolic status may be an important stratification factor when analyzing the relationship between inflammatory levels and subclinical carotid atherosclerosis. The aim of the present study is to assess the relationship between inflammatory levels and subclinical carotid atherosclerosis, stratified by different glucose metabolic status in a general population. METHODS: An assessment was performed in 7975 participants living in Tianjin, China. In the present study, we examined subclinical carotid atherosclerosis, as defined by increased carotid intima-media thickness [IMT] and plaques. Measurements were performed using a carotid artery B-mode ultrasound system. The glucose metabolic status was defined by the criteria of the American Diabetes Association, and high-sensitivity C-reactive protein (hs-CRP) as an inflammatory indicator, was measured by immunoturbidimetric assay. Multiple logistic models were used to assess a stratified relationship between hs-CRP levels and subclinical carotid atherosclerosis. Strata were defined according to glucose metabolic status. RESULTS: The prevalence of increased IMT and plaques were 27.3% and 21.3%, respectively. The adjusted odds ratios (95% confidence interval) for IMT across hs-CRP quartiles were as follows: 1.00 (reference), 1.10(0.88-1.38), 1.08(0.86-1.35) and 1.32(1.06-1.66) in blood glucose-normal subjects; 1.00 (reference), 1.33(0.92-1.91), 1.33(0.93-1.91), and 1.59(1.10-2.30) in prediabetic subjects; 1.00 (reference), 0.94(0.54-1.62), 1.17(0.65-2.12) and 0.98(0.55-1.76) in diabetic subjects, respectively. Similar results were observed for plaques. CONCLUSIONS: Our results suggest that inflammatory levels are differently related to subclinical carotid atherosclerosis by the different glucose metabolic status.
No takes yet. Share an insight, caveat, or question.
Su et al. (2018) conducted a cross-sectional in Subclinical carotid atherosclerosis (n=7,975). High-sensitivity C-reactive protein (hs-CRP) vs. Lowest quartile of hs-CRP was evaluated on Increased carotid intima-media thickness (IMT) (OR 1.59, 95% CI 1.10-2.30, p=0.04). Elevated hs-CRP levels were significantly associated with increased odds of subclinical carotid atherosclerosis in adults with normal glucose metabolism and prediabetes, but this relationship was not observed in patients with type 2 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: